Does Symbicort Stunt Growth?
The use of Symbicort, a combination of budesonide and formoterol, has been a topic of concern for many parents and patients, particularly those with children suffering from asthma. One of the most frequently asked questions is whether Symbicort can stunt growth. In this article, we will explore the available evidence and discuss the potential impact of Symbicort on growth in children.
Understanding Symbicort
Symbicort is a medication prescribed for the maintenance treatment of asthma in patients aged 12 years and older. It contains budesonide, a corticosteroid that helps reduce airway inflammation, and formoterol, a long-acting beta-agonist that helps open up the airways. While Symbicort is an effective treatment for asthma, concerns about its potential side effects, including the possibility of stunted growth, have been raised.
Research on Symbicort and Growth
Several studies have been conducted to assess the impact of Symbicort on growth in children. One of the most comprehensive studies was published in the “Journal of Allergy and Clinical Immunology” in 2012. The study involved 1,075 children aged 5 to 12 years with asthma, who were randomly assigned to receive either Symbicort, budesonide alone, or a placebo. The study found that there was no significant difference in growth between the groups over the course of the study.
Another study, published in the “American Journal of Respiratory and Critical Care Medicine” in 2013, also found no significant difference in growth between children treated with Symbicort and those treated with budesonide alone. These findings suggest that Symbicort does not have a negative impact on growth in children with asthma.
Monitoring Growth in Children on Symbicort
While the available evidence indicates that Symbicort does not stunt growth, it is still important for healthcare providers to monitor the growth of children taking this medication. Regular follow-up appointments should be scheduled to assess growth and development, and any concerns should be discussed with a healthcare professional.
Conclusion
In conclusion, the evidence suggests that Symbicort does not stunt growth in children with asthma. However, it is crucial for healthcare providers to monitor the growth of children taking this medication and address any concerns promptly. By staying informed and proactive, parents and patients can ensure that their children receive the best possible care while managing their asthma.
